Amylyx PharmaceuticalsAMLX
那斯達克 · USD
7.72
-0.32
(-3.92%)
收盤 08/02 03:59 (UTC+8)
盤後
7.40
7.40
(-4.08%)
08/02 03:59 (UTC+8)
Amylyx PharmaceuticalsAMLX
7.72
-0.32
(-3.92%)
財務數據
損益表
- 0.22
- 0.71
- 0.98
- 1.03
- 1.08
- 0.89
- -0.01
- 0.00
- -0.01
- -
- 6243.48
- 226.38
- 37.50
- 4.56
- 5.61
- -18.26
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | -665 | 416 | -1,023 | 88,643 | 108,449 | 102,693 | 98,216 | 71,428 | 21,885 |
營業成本 | - | 0 | 809 | 7,418 | 116,406 | 9,360 | 5,218 | 5,580 | 5,283 | 2,821 |
營業毛利 | - | -665 | -393 | -8,441 | -27,763 | 99,089 | 97,475 | 92,636 | 66,145 | 19,064 |
營業費用 | 37,803 | 39,989 | - | 44,994 | 94,367 | 97,155 | 78,755 | 72,435 | 68,198 | 63,657 |
研發費用 | 22,119 | 22,892 | 21,237 | 23,347 | 36,608 | 44,914 | 30,037 | 29,044 | 24,192 | 22,813 |
推銷及管理費用 | 15,684 | 17,097 | 17,828 | 21,647 | 57,759 | 52,241 | 48,718 | 43,391 | 44,006 | 40,844 |
非經常性項目費用 | - | - | 36,203 | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -37,803 | -40,654 | -75,661 | -53,435 | -122,130 | 1,934 | 18,720 | 20,201 | -2,053 | -44,593 |
其他收入及費用 | 1,896 | - | 2,957 | - | 3,579 | 4,542 | 3,691 | 3,806 | 3,456 | 2,468 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -35,907 | -38,181 | -72,704 | -72,700 | -118,551 | 6,476 | 22,411 | 24,007 | 1,403 | -42,125 |
所得稅 | - | -635 | - | 0 | 242 | 1,745 | 1,518 | 1,933 | -170 | 579 |
稅後純益 | -35,907 | -37,546 | -72,704 | -72,700 | -118,793 | 4,731 | 20,893 | 22,074 | 1,573 | -42,704 |
基本每股稅後盈餘(元) | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.31 | 0.33 | 0.02 | -0.65 |
稀釋每股稅後盈餘(元) | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.29 | 0.32 | 0.02 | -0.62 |
基本平均股數(千股) | 85697.00 | 68593.00 | 68091.00 | 68024.00 | 67854.00 | 67414.00 | 67414.00 | 67233.00 | 66717.00 | 65416.00 |
稀釋平均股數(千股) | 85697.00 | 68593.00 | 68091.00 | 68024.00 | 67854.00 | 69196.00 | 69748.00 | 70132.00 | 70863.00 | 65416.00 |
還原基本每股稅後盈餘(元) | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.31 | 0.33 | 0.02 | -0.65 |
還原稀釋每股稅後盈餘(元) | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.29 | 0.32 | 0.02 | -0.62 |
還原基本平均股數(千股) | 85,697 | 68,593 | 68,091 | 68,024 | 67,854 | 67,414 | 67,414 | 67,233 | 66,717 | 65,416 |
還原稀釋平均股數(千股) | 85,697 | 68,593 | 68,091 | 68,024 | 67,854 | 69,196 | 69,748 | 70,132 | 70,863 | 65,416 |
EBITDA(千元) | -37,454 | -38,021 | -74,788 | -72,492 | -120,818 | 4,205 | 20,231 | 22,305 | -1,296 | -43,803 |